Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Tatyana Makeyeva"

4 mentions found

Kremlin says healthcare under heavy strain as COVID-19 deaths hit new high
  + stars: | 2020-11-24 | by ( Reuters Staff | ) sentiment -0.99   time to read: +2 min
MOSCOW (Reuters) - The Kremlin said on Tuesday Russia’s healthcare system was under heavy strain as authorities reported a record 491 deaths linked to COVID-19 and infections surged. “The healthcare system is working under heavy strain, but with the exception of a few regions...the situation remains under control,” Kremlin spokesman Dmitry Peskov told reporters. Russia’s Sputnik V COVID-19 vaccine will cost less than $20 per person on international markets and Moscow aims to produce more than a billion doses at home and abroad next year, its backers and developers said on Tuesday. Russia has a huge testing programme and is now carrying out four to six times more tests than it was in April, she added. With a population of around 145 million, Russia has the world’s fifth largest number of cases at 2,138,828, after the United States, India, Brazil and France.
Persons: Tatyana Makeyeva, Dmitry Peskov, , , Tatiana Golikova, Anna Popova, Rospotrebnadzor Organizations: REUTERS, COVID, Regulators, Sputnik Locations: MOSCOW, Tver, Russia, Tatyana Makeyeva Russia, Moscow, United States, India, Brazil, France
Eastern Europe crosses over 5 million COVID-19 cases: Reuters tally
  + stars: | 2020-11-21 | by ( Shaina Ahluwalia | ) sentiment -0.88   time to read: +1 min
REUTERS/Tatyana Makeyeva/File Photo(Reuters) - The tally of coronavirus cases in the Eastern European sub-region passed 5 million on Saturday, a Reuters tally showed, as governments across Europe take measures to try to rein in surging cases. The region, which comprises Belarus, Bulgaria, Czech Republic, Hungary, Poland, Moldova, Romania, Russia, Slovakia, and Ukraine, has the highest count of reported COVID-19 cases in Europe. Eastern Europe reported over 82,000 cases in a single day on an average in the last week, while adding over 1,500 deaths daily on average. Russia, Poland, and Ukraine are among the top 20 countries with the most cases in the world. Europe has so far reported over 15 million COVID cases, making it the region with the highest number of cases.
Persons: Tatyana Makeyeva Organizations: REUTERS, Eastern, Reuters Locations: Tver, Russia, Europe, Belarus, Bulgaria, Czech Republic, Hungary, Poland, Moldova, Romania, Slovakia, Ukraine, Eastern Europe, United States, India, Brazil, France, Latin America
MOSCOW (Reuters) - Some Russian hospitals are experiencing serious shortages of drugs used to treat COVID-19 and cannot restock because of panic buying, high demand and problems with a new labelling system, officials, distributors and doctors said. Doctors in over a dozen regions face big shortages of antibiotics, antiviral drugs and other medicines used to treat COVID-9, three local officials and three drugs vendors told Reuters. Russian doctors use a specific programme with specific drugs to treat COVID-19 patients. “The only cure is to pray,” said an official who works in a regional COVID-19 crisis centre. There are just not so many of these drugs available,” said a regional official from a COVID-19 crisis centre.
Persons: Tatyana Makeyeva, Dmitry Peskov, , Anatoly Tenser, Alexander Semenov, Acticomp, Rustem Muratov, ” Nikolai Bespalov Organizations: REUTERS, Reuters, , Binnopharm, RNC Pharma Locations: MOSCOW, Tver, Russia, Moscow, Bashkiria, India, China
Q&A: Where are we in the COVID-19 vaccine race?
  + stars: | 2020-11-09 | by ( Carl O Donnell | ) + 0.00   time to read: +4 min
FILE PHOTO: A nurse prepares Russia's "Sputnik-V" vaccine against the coronavirus disease (COVID-19) for inoculation in a post-registration trials stage at a clinic in Moscow, Russia September 17, 2020. The FDA has asked companies to watch trial participants for side effects for two months after receiving a final vaccine dose. Could these be the first widely available coronavirus vaccines? Sinovac and CNBG have said to expect early trial data as soon as November. Russia has also given the vaccine to at least hundreds of “high-risk” members of the general population.
Persons: Tatyana Makeyeva, Johnson, AstraZeneca, CanSino, Russia’s Organizations: YORK, REUTERS, drugmaker Pfizer Inc, BioNTech, Moderna Inc, AstraZeneca, University of Oxford, Pfizer, World Health Organization, European Medicines Agency, COVID, U.S . Food, Drug Administration, Moderna, FDA, Regulators, China National Biotec, Russia’s Gamaleya Locations: Moscow, Russia, U.S, Britain, United States, Europe, United Kingdom, Canada, China
Total: 4